Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. (2014)
Attributed to:
R Phillips, KNUST Ghana. Pathogenesis and management of M. ulcerans disease, Buruli ulcer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.02165-13
PubMed Identifier: 24323473
Publication URI: http://europepmc.org/abstract/MED/24323473
Type: Journal Article/Review
Volume: 58
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 2
ISSN: 0066-4804